Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.5B | 9.9B | 11.3B | 10.2B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.9M | 26.9M | 133.3M | 25.9M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 0 | 0 | 0 | 0 |
Pretax income | 1.7B | 1.6B | 2.2B | 1.8B |
Tax provision | 420.2M | 402.1M | 549.5M | 436.5M |
Net income | 1.3B | 1.2B | 1.7B | 1.4B |
Basic EPS | 2.6 | 2.4 | 3.3 | 2.7 |
Diluted EPS | 2.6 | 2.4 | 3.3 | 2.7 |
Basic average shares | 514.3M | 516.0M | 511.0M | 512.7M |
Diluted average shares | 514.3M | 516.0M | 511.0M | 512.7M |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | 300K | 1M | -600K | 600K |
Preferred stock dividends | — | — | — | — |